CEREBRAL OXIMETRY MONITORING MARKET

KEY FINDINGS

• Cerebral oximetry monitoring is a non-invasive medical procedure that measures the oxygen saturation of blood in the brain.
• It is used to assess the adequacy of cerebral perfusion, which is the flow of blood to the brain. This information can be used to guide treatment decisions and improve patient outcomes.
• The most common type of cerebral oximetry monitoring uses near-infrared spectroscopy (NIRS). NIRS devices emit light into the brain and then measure the amount of light that is absorbed by the blood. The amount of absorbed light is related to the oxygen saturation of the blood.
• Cerebral oximetry monitoring is used in a variety of medical settings, including, Critical care units, Neurosurgery, Cardiac surgery, Neurocritical care and Emergency rooms.
• Cerebral oximetry monitoring can be used to detect cerebral desaturation, which is a decrease in the oxygen saturation of blood in the brain, and guide treatment decisions, such as adjusting the amount of oxygen being delivered to the patient.
• It is also used to assess the effectiveness of treatment, such as after a stroke or brain injury and Monitor patients at risk of cerebral ischemia, which is a lack of blood flow to the brain.
• An increasing prevalence of neurological disorders such as stroke, brain injury, and epilepsy, which require cerebral oximetry monitoring to assess and manage cerebral oxygenation.
• Increasing technological advancements are making cerebral oximetry monitoring devices more accurate, portable, and easier to use.
• There is a lack of standardization in the use of cerebral oximetry monitoring, which can lead to inconsistencies in data interpretation and make it difficult to compare results from different studies.
• Reimbursement for cerebral oximetry monitoring is often limited or not available, which can make it difficult for hospitals and other healthcare providers to adopt this technology.
• Governments are allocating funds to contribute to the advancement of device technologies, data analysis techniques, and clinical applications, leading to more accurate, reliable, and effective cerebral oximetry monitoring solutions.

MARKET OVERVIEW

North America is the largest market for cerebral oximetry monitoring, followed by Europe. Asia Pacific is expected to be the fastest-growing market during the forecast period due to the rising prevalence of neurological disorders and the increasing adoption of cerebral oximetry monitoring in critical care settings. Increasing technological advancements that are making cerebral oximetry monitoring devices more accurate, portable, and easier to use.

Governments are actively collaborating with industry stakeholders, including device manufacturers, healthcare providers, and patient advocacy groups, to address challenges and identify opportunities for market growth.Governments are fostering international collaboration in the field of cerebral oximetry monitoring to share best practices, exchange knowledge, and promote harmonization of regulatory standards.

North America accounted for the largest share of 37.41% in 2022. The growing prevalence of non-communicable diseases and rising developments in cerebral oximetry devices are the key factors driving market growth in the region

INTRODUCTION

A medical procedure called cerebral near-infrared spectroscopy (NIRS), also known as cerebral oxygenation monitoring, measures the oxygen saturation levels in the brain’s tissue. This monitoring technique offers useful information on the brain’s adequate oxygenation, which is essential for preserving healthy brain function and avoiding neurological disorders.

Near-infrared light, which can penetrate biological tissues to a certain depth, is used during the monitoring procedure. To ascertain the level of brain tissue oxygenation, this light is flashed onto the scalp, and the reflected or transmitted light is examined. The method is based on the fact that near-infrared light is absorbed and scattered differently by oxygenated and deoxygenated haemoglobin molecules.

Cerebral oximetry monitoring are used to monitor cerebral oxygenation during surgical procedures, particularly those requiring cardiac or vascular surgery, and can assist in guaranteeing that the brain is receiving an appropriate quantity of oxygen and blood.Cerebral oximetry can be used in intensive care units (ICUs) to evaluate the oxygenation status of the brain in patients with traumatic brain injuries, strokes, or other neurological diseases.

In neonatology, cerebral oximetry is used to track the amount of oxygen in newborns’ brains, particularly those who were born prematurely or with disorders that might impair brain oxygenation. In order to keep the appropriate levels of brain oxygen during surgery, anaesthesia doctors can employ cerebral oximetry to direct the delivery of anaesthetic.

Healthcare professionals can make educated judgments about patient care by continuously monitoring cerebral oxygen levels, perhaps identifying and resolving problems related to insufficient brain oxygenation before they result in major complications. However, it’s crucial to remember that while cerebral oximetry offers insightful data, it is only one component of a thorough evaluation of a patient’s overall state.

CEREBRAL OXIMETRY MONITORING MARKET SIZE AND FORECAST

The Global Cerebral Oximetry Monitoring Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

TRENDS 

• Miniaturization of devices:Cerebral oximetry monitoring devices are becoming increasingly smaller and more portable, making them easier to use in a wider range of settings, including home care and ambulance transportation.

• Advanced sensor technology:New sensor technologies are being developed that are more accurate and reliable, and that can measure cerebral oxygenation in a wider range of patients, including those with dark skin or thick hair.

• Wireless connectivity:Cerebral oximetry monitoring devices are becoming increasingly connected, allowing for real-time data transmission to clinicians and patient monitoring systems.

• Integration with artificial intelligence (AI):AI is being used to develop algorithms that can automatically analyze cerebral oximetry data and provide real-time insights to clinicians.

• Medtronic and Phillips Announce Collaboration to Develop Next-Generation Cerebral Oximetry Monitoring Technology: The collaboration is expected to lead to the development of new devices that can be used to monitor cerebral oxygenation in a wider range of patients, including those with dark skin or thick hair.

NEW PRODUCT LAUNCH

Masimo Announces FDA Clearance of Next-Generation Root Monitor with Regional Oximetry:

Masimo Corporation announced on Oct 4, 2023 that it has received FDA clearance for its next-generation Root Monitor with regional oximetry (rSO2), a breakthrough device that provides noninvasive and continuous monitoring of cerebral oxygen saturation (rSO2) in adult and pediatric patients.

The Root Monitor with rSO2 is the latest innovation in Masimo's portfolio of cerebral oximetry monitoring devices. It is designed to provide clinicians with even more accurate and reliable data, as well as new features that make it easier to use.

Integra LifeSciences Launches New Cerebral Oximetry Monitoring Device:

Integra LifeSciences announced on September 22, 2023 that it has launched a new cerebral oximetry monitoring device called the INVOS 5100 Monitor. The new device is designed to provide clinicians with more accurate and reliable data, as well as new features that make it easier to use.

The INVOS 5100 Monitor is the latest innovation in Integra LifeSciences' portfolio of cerebral oximetry monitoring devices. It is designed to be used in a variety of healthcare settings, including critical care, operating rooms, and emergency rooms.

Nonin Medical Announces FDA Clearance of New Cerebral Oximetry Monitoring Device:

Nonin Medical announced on September 15, 2023 that it has received FDA clearance for its new cerebral oximetry monitoring device called the NIRS-5000 Monitor. The new device is designed to provide clinicians with more accurate and reliable data, as well as new features that make it easier to use.

The NIRS-5000 Monitor is the latest innovation in Nonin Medical's portfolio of cerebral oximetry monitoring devices. It is designed to be used in a variety of healthcare settings, including critical care, operating rooms, and emergency rooms.

MARKET SEGMENTATION

By Product Type

• Continuous cerebral oximetry monitoring devices
• Near-infrared spectroscopy (NIRS) devices

By Application

• Neurocritical care
• Cardiac surgery
• Neurosurgery
• Other applications

By End-user

• Hospitals
• Clinics
• Home care settings

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

COMPANY PROFILED

• Masimo Corporation
• Medtronic
• Integra LifeSciences
• Philips Healthcare
• Nonin Medical Inc.

THIS REPORT WILL ANSWER THE FOLLOWING QUESTIONS

1. How many Cerebral Oximetry Monitoring are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Cerebral Oximetry Monitoring and key vendor selection criteria.
3. What are the ethical considerations of using cerebral oximetry monitoring?
4. What is the future of cerebral oximetry monitoring?
5. Where is the Cerebral Oximetry Monitoring manufactured? What is the average margin per unit?
6. Market share of Global Cerebral Oximetry Monitoring market manufacturers and their upcoming products.
7. Cost advantage for OEMs who manufacture Global Cerebral Oximetry Monitoring in-house.
8. key predictions for next 5 years in the Global Cerebral Oximetry Monitoring market.
9. Average B-2-B Cerebral Oximetry Monitoring market price in all segments.
10. Latest trends in the Cerebral Oximetry Monitoring market, by every market segment.
11. The market size (both volume and value) of the Cerebral Oximetry Monitoring market in 2024-2030 and every year in between?
12. Production breakup of the Cerebral Oximetry Monitoring market, by suppliers and their OEM relationship.